Serotonin 5-HT(2C) receptor RNA editing alters receptor basal activity: Implications for serotonergic signal transduction

Journal of Neurochemistry

Volumn 73, Issue 4, 1999, Pages 1711-1717

  Herrick Davis, Katharine ^a   Grinde, Ellinor ^a   Niswender, Colleen M ^b  

^a ALBANY MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Basal activity; Inositol phosphate; RNA editing; Serotonin 5 HT(2C) receptor

Indexed keywords

INOSITOL PHOSPHATE; ISOPROTEIN; MESULERGINE; SEROTONIN; SEROTONIN 2C RECEPTOR; ERGOLINE DERIVATIVE; MIANSERIN; PARGYLINE; RECOMBINANT PROTEIN; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR;

ANIMAL CELL; ARTICLE; BINDING COMPETITION; CHEMICAL REACTION KINETICS; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; MEDIATOR RELEASE; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR AFFINITY; RNA EDITING; SEROTONINERGIC SYSTEM; SIGNAL TRANSDUCTION; ANIMAL; CELL STRAIN COS1; GENETIC TRANSFECTION; GENETICS; KINETICS; METABOLISM; PHYSIOLOGY; SITE DIRECTED MUTAGENESIS;

ANIMALS; COS CELLS; ERGOLINES; HUMANS; INOSITOL PHOSPHATES; KINETICS; MIANSERIN; MUTAGENESIS, SITE-DIRECTED; PARGYLINE; RATS; RECEPTOR, SEROTONIN, 5-HT2C; RECEPTORS, SEROTONIN; RECOMBINANT PROTEINS; RNA EDITING; SEROTONIN; SEROTONIN ANTAGONISTS; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 0032589301     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1999.731711.x     Document Type: Article

References (35)

1. Arora K. K., Sakai A., and Catt K. J. (1995) Effects of second intracellular loop mutations on signal transduction and internalization of the gonadotropin-releasing hormone receptor. J. Biol. Chem. 270, 22820-22826.
2. Ballesteros J., Kitanovic S., Guarnieri F., Davies P., Fromme B. J., Konvicka K., Chi L., Millar R. P., Davidson J. S., Weinstein H., and Sealfon S. C. (1998) Functional microdomains in G-protein-coupled receptors: the conserved arginine-cage motif in the gonadotropin-releasing hormone receptor. J. Biol. Chem. 273, 10445-10453.
3. 2C receptors reveal novel inverse agonist activity of receptor ligands. J. Biol. Chem. 269, 11687-11690.
4. Berg K. A., Clarke W. P., Sailstad C, Saltzman A., and Maayani S. (1994) Signal transduction differences between 5-hydroxytryptamine type 2A and type 2C receptor systems. Mol. Pharmacol. 46, 477-485.
5. 1B-like receptor function via arachidonic acid metabolism. Mol. Pharmacol. 50, 1017-1023.
6. Berg K. A., Maayani S., Goldfarb J., Scaramellini C., Leff P., and Clarke W. P. (1998) Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: evidence for agonist-directed trafficking of receptor stimulus. Mol. Pharmacol. 54, 94-104.
7. Burns C. M., Chu H., Rueter S. M., Hutchinson L. K., Canton H., Sanders-Bush E., and Emeson R. B. (1997) Regulation of serotonin-2C receptor G-prolein coupling by RNA editing. Nature 387, 303-308.
8. Chen S. H., Habib G., Yang C. Y., Gu Z. W., Lee B. R., Weng S. A., Silberman S. R., Cai S. J., Deslypere J. P., Rosseneu M., Gotto A. M., Li W. H., and Chan L. (1987) Apolipoprotein B-48 is the product of a messenger RNA with an organ-specific in-frame translational stop codon. Science 328, 363-366.
9. 1-adrenergic receptor involved in coupling to phosphatidylinositol hydrolysis and enhanced sensitivity of biological function. Proc. Natl. Acad. Sci. USA 87, 2896-2900.
10. 2A receptor by site-directed mutagenesis: inverse agonist activity of antipsychotic drugs. J. Pharmacol. Exp. Ther. 286, 85-90.
11. 2C receptor. Neuropsychopharmacology (in press).
12. 2C receptor. J. Neurochem. 69, 1138-1144.
13. 2C receptor. Ann. NY Acad. Sci. 861, 140-146.
14. 2+ permeability of KA-AMPA-gated glutamate channels depends on subunit composition. Science 252, 851-853.
15. Hoyer D., Clarke D., Fozard J., Hartig P., Martin G., Mylecharane E., Saxena P., and Humphrey P. (1994) International Union of Pharmacology classification of receptors for 5-hydroxytryptamine. Pharmacol. Rev. 46, 157-203.
16. Kenakin T. (1995) Agonist-receptor efficacy. II: Agonist trafficking of receptor signals. Trends Pharmacol. Sci. 16, 232-238.
17. Meltzer H. Y., Matsubara S., Lee J. C., Toth M., and Shenk T. (1989) Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values. J. Pharmacol. Exp. Ther. 251, 238-246.
18. Moro O., Lameh J., Hogger P., and Sadee W. (1993) Hydrophobic amino acid in the i2 loop plays a key role in receptor-G protein coupling. J. Biol. Chem. 268, 22273-22276.
19. Niswender C. M., Sanders-Bush E., and Emeson R. B. (1998a) Identification and characterization of RNA editing events within the serotonin2C receptor. Ann. NY Acad. Sci. 861, 38-48.
20. Niswender C. M., Copeland S. C., Dilley G. E., Meltzer H. Y., Overholser J. C., Stockmeier C. A., Emeson R. B., and Sanders-Bush E. (1998b) RNA editing of human serotonin 2C receptor transcripts. Soc. Neurosci. Abstr. 24, 1098.
21. Niswender C. M., Copeland S. C., Herrick-Davis K., Emeson R. B., and Sanders-Bush E. (1999) RNA editing of the human serotonin 5-hydroxytryptamine 2C receptor silences constitutive activity. J. Biol. Chem. 274, 9472-9478.
22. Parma J., Duprez L., VanSande J., Cochaux P., Gervy C., Mockel J., Dumont J., and Vassart G. (1993) Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature 365, 649-651.
23. Powell L. M., Wallis S. C., Pease R. J., Edwards Y. H., Knott T. J., and Scott J. (1987) A novel form of tissue-specific RNA processing produces apolipoprotein B48 in intestine. Cell 50, 831-840.
24. Rao V. R., Cohen G. B., and Oprian D. D. (1994) Rhodopsin mutation G90D and a molecular mechanism for congenital night blindness. Nature 367, 639-642.
25. 1C receptors. J. Pharmacol. Exp. Ther. 260, 1361-1365.
26. Roth B. L., Craigo S. C., Choudhary M. S., Uluer A., Monsma F. J., Shen Y., Meltzer H. Y., and Sibley D. R. (1994) Binding of typical and atypical antipsychotic agents to 5-hydroxytryplamine-6 and 5-hydroxytryptamine-7 receptors. J. Pharmacol. Exp. Ther. 268, 1403-1410.
27. 2C): where structure meets function. Pharmacol. Ther. 79, 231-257.
28. 2-adrenergic receptor: extending the ternary complex model. J. Biol. Chem. 268, 4625-4636.
29. 1B-adrenergic receptor: role of highly conserved polar amino acids in receptor activation. EMBO J. 15, 3566-3578.
30. 1B-adrenergic receptor: potential role of protonation and hydrophobicity of a highly conserved aspartate. Proc. Natl. Acad. Sci. USA 94, 808-813.
31. Schipani E., Kruse K., and Juppner H. (1995) A constitutively active mutant PTH-PTHrP receptor in Jansen-type metaphyseal chondrodysplasia. Science 268, 98-102.
32. Shenker A., Laue L., Kosugi S., Merendino J. J., Minegishi T., and Cutler G. B. (1993) A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty. Nature 365, 652-654.
33. Sommer B., Kohler M., Sprengel R., and Seeburg P. (1991) RNA editing in brain controls a determinant of ion flow in glutamate-gated channels. Cell 67, 11-19.
34. Verdoorn T. A., Burnashev N., Monyer H., Seeburg P. H., and Sakmann B. (1991) Structural determinants of ion flow through recombinant glutamate receptor channels. Science 252, 1715-1718.
35. Westphal R. S., Backstrom J. R., and Sanders-Bush E. (1995) Increased basal phosphorylation of the constitutively active serotonin 2C receptor accompanies agonist-mediated desensitization. Mol. Pharmacol. 48, 200-205.